We applied logistic regression analysis to a group of 736 patients with chest pain to determine which radionuclide angiographic (RNA) parameters were most useful in the diagnosis of significant coronary artery disease. The most useful parameters were exercise ejection fraction, exercise heart rate, "ischemia score," and the presence of a regional wall motion abnormality at exercise. Ten clinical variables were used in one logistic regression model to estimate each patient's pretest probability of disease. A second logistic regression model considered these clinical variables and the four important RNA parameters to estimate each patient's posttest probability. These models were applied prospectively to a group of 76 patients with chest pain who did not have a high pretest probability of disease. Twenty-four patients (32%) could be diagnosed with 90% probability; 32 patients (42%) could be diagnosed with 85% probability. RNA testing is therefore helpful in the noninvasive diagnosis of coronary artery disease. However, a majority of patients who do have a low or intermediate pretest probability of disease will require additional testing for a definitive diagnosis.
RESULTS OF A number of studies in which gated equilibrium or first-class radionuclide angiography (RNA) were used suggest that the change in ejection fraction from rest to exercise is useful in the noninvasive diagnosis of coronary artery disease. -' Previous studies from this laboratory6' have shown that the ejection fraction response to exercise is a complex parameter that is influenced by multiple physiologic variables other than the presence or severity of coronary artery disease. We have also shown that the sensitivity of RNA testing seems to be reduced in women and men with atypical angina. 5 Since these patient groups are those in which the test would be most appropriately performed for diagnostic purposes, these results have suggested that RNA testing might be of limited diagnostic utility.
Discriminant analysis has been applied to other clinical situations to determine which factors are most significant in distinguishing normal from abnormal patients. 8 10 The present study applies logistic regression analysis to RNA testing to determine which RNA parameters are most useful for the diagnosis of coronary artery disease. A logistic regression function in which these variables, as well as 10 different clinical variables, are used was then applied prospectively to a group of patients with chest pain to evaluate the potential importance of RNA testing in the noninvasive diagnosis of coronary artery disease.
Methods
Study population. Group I (retrospective) consisted of 736 patients with chest pain who underwent coronary angiographic examination and upright rest and exercise RNA between January 1, 1978 and March 1, 1981 . All patients underwent RNA within 3 months of coronary arteriography. Patients with significant valvular heart disease or previous coronary artery or left ventricular surgery were excluded. Group IA consisted of 299 patients from group I who satisfied two additional requirements: they did not have significant electrocardiogram (ECG) Q waves and they were not men 40 years old or older with typical angina. Group IIA (prospective) consisted of an additional 76 patients with chest pain who underwent both coronary angiography and rest and exercise RNA studies between March 1, 1981 and March 1, 1982 . Patients in group IIA satisfied the same two additional requirements listed above for group IA. Fifty-six percent of the patients in group IA and 57% of the patients in group IIA were women.
Baseline information. The computerized information system used in this study has been described in detail.' In summary, a baseline data set composed of multiple noninvasive clinical characteristics and catheterization variables were collected prospectively at the time of catheterization for each patient. Each patient's chest pain was characterized as nonanginal, atypical angina, or typical angina. ECG Q waves were considered significant if they exceeded 0.04 sec in leads I, II, aVL, aVF, or V3 to V6.
RNA study. All studies were performed in patients in the sitting position and by previously described techniques. '2' 13 After an RNA at rest, subjects began exercise on a bicycle ergometer at a workload of 200 kilopond-meters (kpm)/min. The workload was progressively increased by 100 kpmlmin each minute until one of the following occurred: (1) moderate chest pain, (2) positive ECG changes (0.1 mV of downsloping or horizontal ST depression), (3) achievement of 85% of maximum predicted heart rate, or (4) severe fatigue. At peak exercise RNA was repeated and heart rate, blood pressure, and peak workload were recorded. The exercise end point was assigned an "ischemia score" based on the presence of moderate chest pain and/or positive ECG changes. If both were present, the ischemia score was assigned the value of 2. If one of the two was present, the score was 1; if neither was present, the score was 0. Although arbitrary, such a score is a reasonable clinimetric scale'4 for exercise end point.
The details of the RNA procedure have previously been reported.'2' 13 An anterior projection and a multicrystal gamma camera (Baird System Seventy-Seven) were employed to record counts over the chest wall at 25 msec intervals for 1 min. Data processing. Radionuclide data were processed with the computer and software of the Baird System Seventy-Seven.'2' 13 Corrections were made for background immediately before injection, electronic dead time loss, and detector nonuniformity. End-systolic and end-diastolic frames were identified from count changes within the left ventricle. Data from 3 to 6 sequential beats was added to form an average or representative cardiac cycle. Ejection fraction (EF) was calculated from the background-corrected representative cardiac cycle as [(ED-ES)/ ED] x 100, where ES = end-systolic counts and ED = enddiastolic counts. The end-diastolic perimeter was considered to be at the 21% isocount contour of the end-diastolic image. '5 This perimeter was used to calculate an end-diastolic volume with the area-length method of Sandler and Dodge.'6 The enddiastolic volume index was determined by dividing end-diastolic volume by body surface area. Validation studies for EF and end-diastolic volume, including interobserver variability at rest and exercise, have been previously published.'2' 13 The EF response to exercise (AEF) was defined as exercise EF minus resting EF.
Regional left ventricular function was assessed at rest and at exercise by analysis of wall motion through both the cinematic display of the representative cycle and the static display of the end-diastolic and end-systolic perimeters. A uniform decrease in wall motion was not considered a regional abnormality. An exercise wall motion abnormality was present during exercise regardless of whether or not it was present at rest.
Cardiac catheterization. The cardiac catheterization procedure followed at this institution has been previously reported. "7 Selective coronary angiograms were recorded in multiple left anterior oblique and right anterior oblique projections. They were interpreted in conference by at least two of the same three Vol. 68, No. 4, October 1983 experienced angiographers. Lesions estimated to be causing 75% or more narrowing of the luminal diameter were considered significant. Data analysis. Group I was randomly divided into two subgroups of equal size. A logistic regression model was developed with data from the first of these subgroups to distinguish patients with from those without significant coronary artery disease. A total of 37 different RNA variables were considered for entry in a stepwise fashion (table 1). The first variable chosen was the one that provided the most significant discriminative information. At each subsequent step, the variable chosen was that which provided the most significant additional information after adjustment for those variables already entered. Additional variables were entered until they were no longer significant at the p < .05 level. The validity of the model developed by this procedure was then tested by applying it to the second subgroup. Once the important RNA parameters were identified and validated, two logistic regression functions were developed with data from all patients in group I to identify the presence or absence of coronary artery disease. The first function considered 10 clinical variables that we have previously identified'8 as important for the diagnosis of the presence of disease (table 2) to estimate the pretest probability of disease for each patient. The second function used these clinical variables and the important RNA variables to estimate the posttest probability of disease for each patient.
These two logistic regression functions were then applied retrospectively to group IA and prospectively to group IIA to estimate the pretest and posttest probabilities for each patient in these groups. Computations for the logistic regression analysis were performed with the SAS (Statistical Analysis System) logistic computer procedure. The significance of specific combinations of variables with the model was assessed with the likelihood ratio chi-square statistic.
Results
Important RNA variables. When stepwise logistic regression analysis was applied to the first of the two random subgroups of group I, four different RNA variables were identified as significant independent contributors to the identification of the presence or absence of coronary artery disease. In order of importance, these four variables were exercise EF, exercise heart rate, the ischemia score, and the presence of a regional wall motion abnormality at exercise. Given the exercise EF, AEF did not provide any additional discriminative information. The overall model was highly significant (X2 = 124; p < .0001). When this model was tested in the second of the two random subgroups of group I, the model remained highly significant (X2 = 134; p < .0001); each of the four individual variables also remained significant, confirming their validity.
Importance of clinical and RNA variables. The relative significance of clinical and RNA variables is shown in table 3. Results of use of the model to estimate pretest probability (clinical variables alone) were highly significant (X2 = 295; p < .001). When RNA and clinical variables were considered together to estimate posttest 742 probability, there was a significant increase in the model's discriminative power (X2 = 396; p < .001).
With this combined set of variables, exercise EF, exercise heart rate, and the ischemia score remained individually significant, but the presence of a regional wall motion abnormality at exercise was only of borderline significance (p .055). Application of the logistic regression functions. The logistic regression functions were applied to group IA to determine the pretest and posttest probability for each patient (figure 1). One hundred fifty-three patients (51%) in group IA did not have significant coronary artery disease. Before RNA testing, their median probability value was 36%, with a 25th percentile of 17% and a 75th percentile of 52% (figure 1). After RNA testing the 25th, 50th (median), and 75th percentiles all decreased to 9%, 23%, and 38%, respectively. The 146 patients (49%) with coronary artery disease had a median pretest probability of 64% that increased modestly to 74% after the RNA testing. The 75th percentile probability increased from 75% to 91% after RNA testing.
The results of the prospective application of the logistic regression functions to group IIA are shown in figure 2 . Of the 76 patients in group IIA, only eight patients (11%) could be classified with a 90% probability of disease on the basis of clinical variables. Two patients had significant coronary artery disease despite a low (< 10%) pretest probability. Following RNA, 24 patients, or 32%, could be classified with a 90% probability (12 of these 24 patients were women). Sixteen of the 17 patients with a high probability (> 90%) of disease had significant coronary artery disease. Five of the seven patients with a low probability percentiles. The difference in the 25th to 75th percentile range between patients with and without disease is widened considerably after RNA testing.
(< 10%) of disease did not have significant coronary artery disease; the remaining two patients were the same individuals who had significant coronary artery disease despite a low pretest probability. When the analysis was repeated using an 85% threshold for diagnosis, 17 patients, or 22%, could be diagnosed before RNA, and 32 patients, or 42%, could be diagnosed after RNA (figure 3). Of these 32 patients, 16 were women.
Discussion
Previous studies evaluating the diagnostic utility of RNA have focused on its sensitivity and specificity. A wide variety of abnormal criteria have been used with varying degrees of success. The AEF, the exercise EF, and the presence of regional wall motion abnormalities with exercise have all been used to define abnormal tests. l-5
The present study is the first to apply formal regres- Probability (%) FIGURE 3 . Display of the percentage of the 76 patients in group IIA that could be classified with a given probability before (dashed line) and after (solid line) RNA testing. sion methods to RNA testing to determine which parameters are most useful in distinguishing patients with coronary artery disease from those without it. This analysis demonstrates that the RNA parameter that has received the greatest attention, the A\EF, is not the most diagnostically useful. This finding is consistent with our previous observations that the AEF is a complex parameter that is influenced by multiple physiologic variables other than the presence or severity of coronary artery disease.6' 7 End-systolic volume and the ratio of systolic blood pressure to end-systolic volume, two other parameters that have attracted interest in diagnosis, were also not among the most diagnostically useful variables. Exercise EF is the single most important diagnostic RNA parameter, but three other parameters provide additional diagnostic information. Of the four important variables, only two exercise EF and regional wall abnormalities with exercise have been used previously by others2 in the radionuclide diagnosis of coronary artery disease. Exercise heart rate and the ischemia score have not been previously reported in RNA diagnosis, although both have been used in electrocardiographic stress testing. Exercise heart rate is a measure of the degree of exercise stress. The inclusion of the ischemia score suggests that symptomatic or electrocardiographic evidence of ischemia must be considered in addition to the measurement of EF and wall motion. These factors have undoubtedly been considered by clinicians in the evaluation of RNA test results before now, but the present study provides the first evidence to support their independent value.
Although sensitivity and specificity may be useful descriptors of test performance, they must be combined with a knowledge of disease prevalence (pretest probability) to determine the probability of disease af-744 ter a test has been performed (posttest probability). 1'21 Previous assessments of the sensitivity and specificity of RNA testing have included patients with typical angina and ECG Q waves who have a high likelihood of disease. However, diagnostic testing is of most benefit in patients who have an intermediate pretest probability of disease.'9-22The present study is the first effort to evaluate the probability of coronary artery disease after RNA testing in a patient population with a low-to-intermediate prevalence of disease. This analysis does not characterize RNA results as "normal" or "abnormal" according to some arbitrary standard. It considers each patient's clinical characteristics and the four descriptors of the RNA test results to obtain an accurate posttest estimate of the probability that the patient has significant coronary artery disease. Previous studies have emphasized the advantage of considering a patient's actual test performance rather than an arbitrary abnormal threshold.23 24 Patients with ECG Q waves and men 40 years old or older with typical angina were not included in groups IA or IIA because they have a high pretest probability of disease20' 25 and do not therefore require additional testing solely for the purpose of diagnosis. Group IA (retrospective) had a prevalence of coronary artery disease of 51% and a wide range of pretest probability when clinical characteristics were considered. There was some difference in pretest probability between those patients in group IA with significant disease and those without significant disease, but this difference widened considerably after RNA testing. The prevalence of coronary artery disease in the prospective study group (group IIA) of 76 patients was 54%. Only eight of these patients could be classified with a 90% probability on the basis of their clinical characteristics. After RNA testing 24 patients, or 32% of the study CIRCULATION 40 _ 20 _ group, could be classified with a 90% probability; 12 of these 24 patients were women. Although the diagnostic probability required in an individual patient is a matter of clinical judgment, most of these patients would not seem to need further noninvasive or invasive testing for the purpose of diagnosis. If 85% probability was considered acceptable for diagnosis, 42% of the prospective study group could have avoided the expense, morbidity, and risk of additional diagnostic testing.
A previous study from the Coronary Artery Surgery Study9 group applied discriminant analysis to clinical and exercise treadmill variables to determine the probability of coronary artery disease in men. In men with probable angina (comparable to our atypical angina), they found that only approximately 10% of the men could be diagnosed with 80% certainty by treadmill exercise testing. In men with nonspecific chest pain, exercise testing added very little to clinical data for the purpose of diagnosis. Although the differences in patient population and methods of analysis make comparison difficult, RNA testing appears superior to treadmill testing on the basis of the current findings.
Two previous studies have applied discriminant analysis to thallium perfusion imaging.26'27 They are not, however, comparable to the present study, as they included large numbers of patients with definite ECG Q waves and an indeterminate number of patients with typical angina. The only previous study that applied a probabilistic format to RNA23 used Bayes' theorem and pooled data from the literature for rest and exercise EF, but did not determine how many patients could be categorized with a high degree of certainty.
Our study has several important limitations. First, it is based on data from a tertiary referral center at which the decision to perform coronary angiography may have been influenced by exercise treadmill and RNA results. This may limit its applicability to less selected community populations. Second, upright exercise and a multicrystal camera were used for the RNA procedure. The particular coefficients from our logistic regression model would not necessarily apply to gated equilibrium studies in which supine exercise and a single crystal gamma camera are used. Third, we have not considered other exercise ECG parameters such as magnitude of ST depression or duration of ST depression after exercise termination. Finally, we have not attempted to incorporate the results of other noninvasive tests, e.g., cardiac fluoroscopy, that may have refined the assessment of both pretest and posttest probabilities and may have permitted highly accurate diagnoses in a greater number of patients. Despite these limitations, results of the present study do indicate that exercise EF, exercise heart rate, presence of chest pain or ECG changes during exercise, and the presence of regional wall motion abnormalities with exercise are the most useful RNA variables for the diagnosis of coronary artery disease. The use of these variables along with clinical characteristics in a population with uncertain diagnosis permitted the classification of 32% of the patients with 90% probability of disease and of 42% of the patients with 85% probability. RNA testing therefore appears to be helpful in the noninvasive diagnosis of coronary artery disease. However, a majority of patients with a low-tointermediate pretest likelihood of disease will require additional diagnostic testing. 
